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Dyslipidaemia in Africa—
comment on a recent 
systematic review
The publication of the systematic 
review by Jean Jacques Noubiap 
and colleagues1 in The Lancet Global 
Health highlights two important 
issues. The first issue is the trend to 
systematically review data according 
to well established formula, but in the 
absence of a thorough understanding 
of the field and expertise. Many 
systematic reviews are produced by 
professional reviewers with little topic-
specific knowledge. In Noubiap and 
colleagues’1 systematic review, data 
are presented including three studies 
from Uganda; however, these three 
articles cover the same study, although 
the focus of each article was different. 
The second issue is the desire to 
summarise Africa. Currently, the UN 
recognises 54 countries on what is the 
second largest (and arguably the most 
diverse) continent in the world, both 
in terms of land area and population. 
With such wide heterogeneity of 
results across the studies included in 
Noubiap and colleagues’1 review, a 
summary estimate should not have 
been calculated. There is little value in 
saying that the prevalence of low HDL 
in Africa is 41%, when the range is from 
2% to 96% (the lowest and highest 
prevalence estimates were from studies 
conducted in the same country). 
Systematic reviews can be valuable, but 
they can also be misleading.
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